Nucleus is a venture studio focused on the psychedelics industry, dedicated to building innovative brands and assets. By aggregating data and educating stakeholders, Nucleus connects key players in financial services, business services, and healthcare, fostering growth and collaboration within this emerging sector.
Greater London, • United Kingdom
Singapore • Biotechnology
Next-generation domain antibody therapies, Modular antibody design technology, Bi- and tri-specific antibodies, Antibody-drug conjugates (ADCs), Intracellular antibody development